Autori: Korsholm Lars
Naslov | A New Dosing Model Based on Body Mass Index to Guide Factor VIII Dosing in Patients with Hemophilia A (Meeting Abstract) |
Autori | Tiede Andreas Goldmann Georg Miljic Predrag S Korsholm Lars Matytsina Irina Persson Paula Jelev Lissitchkov Toshko |
Info | BLOOD, (2018), vol. 132 br. , Suppl. 1, str. - |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Long-term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trial (Article) |
Autori | Lentz Steven R Janic Dragana M Kavakli Kaan Miljic Predrag S Oldenburg Johannes Ozelo Margareth Castro Santagostino Elena Suzuki Takashi Zupancic-Salek Silva Korsholm Lars Matytsina Irina Tiede Andreas |
Info | HAEMOPHILIA, (2018), vol. 24 br. 6, str. E391-E394 |
Projekat | Novo Nordisk A/S |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Use of turoctocog alfa for less-frequent prophylaxis in selected patients has comparable efficacy with the overall prophylaxis cohort in Guardian (TM) 2 (Meeting Abstract) |
Autori | Tiede Andreas Janic Dragana M Ozelo M Santagostino E Korsholm Lars Matytsina Irina Lentz SR |
Info | HAEMOPHILIA, (2018), vol. 24 br. , Suppl. S1, str. 52-52 |
Projekat | Alnylam; Baxter/Baxalta/Shire; Bayer; Biogen Idec; Biotest; CSL Behring; Novo Nordisk A/S; Octapharma; Pfizer; Roche; Sobi; Baxter; Shire |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|